Article Details

Celldex Therapeutics Initiates Global Phase 3 Program for Barzolvolimab in Patients with ...

Retrieved on: 2024-07-16 14:50:12

Tags for this article:

Click the tags to see associated articles and topics

Celldex Therapeutics Initiates Global Phase 3 Program for Barzolvolimab in Patients with .... View article details on hiswai:

Excerpt

Barzolvolimab, a novel monoclonal antibody, works upstream of other treatment approaches for CSU, targeting the root driver of the disease—mast ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up